These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3212263)

  • 1. [Thymostimulin as an adjuvant to antineoplastic chemotherapy. Experience with patients with myeloma and lymphoma].
    Cánovas Fernández A; González de Zárate P; Alonso Alonso J; Aguirre Errasti C
    Rev Clin Esp; 1988 Nov; 183(7):340-3. PubMed ID: 3212263
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of thymostimulin in lymphoma and myeloma patients].
    Cánovas Fernández A; Alonso Alonso J; González de Zárate P; García Masdevall MD; Riñón Martínez-Gallo M; Aguirre Errasti C
    An Med Interna; 1991 Feb; 8(2):69-73. PubMed ID: 1893006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 4. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G
    G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of infection and improvement of cenesthesia with thymostimulin during chemotherapy following mastectomy].
    Alba E; Visentin L; Farina C; Wierdis T
    Minerva Ginecol; 1991 Dec; 43(12):585-7. PubMed ID: 1819777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative-kinetic aspects of granulocytic resistance to infection in hematologic systemic diseases with reference to antineoplastic chemotherapy].
    Sommer S
    Z Arztl Fortbild (Jena); 1988; 82(11):513-5. PubMed ID: 3176536
    [No Abstract]   [Full Text] [Related]  

  • 8. [Natulan (experimental and clinical data on its antitumor effect)].
    Brodskaia NA
    Vopr Onkol; 1972; 18(11):101-9. PubMed ID: 4566561
    [No Abstract]   [Full Text] [Related]  

  • 9. Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma.
    Naumann F; Weingart O; Kruse E; Schulz H; Bohlius J; Hülsewede H; Engert A;
    J Natl Cancer Inst; 2006 Aug; 98(16):E2. PubMed ID: 16912255
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative immunoglobulin determination as a monitoring technic in hematologic diseases under cytostatic therapy].
    Knolle J; Wörz R; Meyer zum Büschenfelde
    Verh Dtsch Ges Inn Med; 1969; 75():492-7. PubMed ID: 4099583
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy in non-Hodgkin lymphoma].
    Bremer K; Meusers P; Brittinger G
    Internist (Berl); 1980 Sep; 21(9):512-28. PubMed ID: 7005175
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on antineoplastic chemotherapy of malignant lymphoma and the period of survival, with special reference to lymphatic reticulum cell sarcoma].
    Sakai Y
    Naika; 1968 Sep; 22(3):651-61. PubMed ID: 4884751
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with combined chemotherapy of malignant lymphoma].
    Klener P; Donner L
    Vnitr Lek; 1975 Oct; 21(10):986-91. PubMed ID: 1242547
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of the lymphomas.
    Lacher MJ
    Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
    [No Abstract]   [Full Text] [Related]  

  • 15. Sodium and potassium excretion changes and bone marrow recovery after chemotherapy.
    Kiss I; Tomasek J
    Stem Cells; 1999; 17(4):233-4. PubMed ID: 10437987
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytostatic therapy of hemoblastosis].
    Ehrhart H
    Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
    [No Abstract]   [Full Text] [Related]  

  • 17. Single dose of filgrastim (rhG-CSF) to predict mobilisation of haemopoietic progenitors in patients with haematological malignancies.
    Mijovic A; Mufti GJ
    Bone Marrow Transplant; 1995 May; 15(5):813-4. PubMed ID: 7545491
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of lymphomas with antineoplastic agents.
    Brunk SF
    J Iowa Med Soc; 1968 Oct; 58(10):1038-41. PubMed ID: 4884154
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
    Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
    Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current therapy of malignant blood diseases].
    de Werra P
    Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.